Abstract
The Expert Panel for Cosmetic Ingredient Safety reviewed updated information that has become available since their original assessment from 1980, along with updated information regarding product types, and frequency and concentrations of use, and reaffirmed their original conclusion that Imidazolidinyl Urea is safe as a cosmetic ingredient in the practices of use and concentration as described in this report.
Current and Historical Frequency and Concentration of Use of Imidazolidinyl Urea According to Duration and Exposure.
*Because each ingredient may be used in cosmetics with multiple exposure types, the sum of all exposure types may not equal the sum of total uses.
aIt is possible these products are sprays, but it is not specified whether the reported uses are sprays.
bNot specified whether a spray or a powder, but it is possible the use can be as a spray or a powder; therefore, the information is captured in both categories.
cIt is possible these products are powders, but it is not specified whether the reported uses are powders.
NR, not reported.
The reported frequency of use for this ingredient has decreased significantly since the initial re-review was considered. According to VCRP data, Imidazolidinyl Urea was reported to be used in 2025 formulations in 2001. 2 In 2019, VCRP data indicate that Imidazolidinyl Urea is used in 1558 formulations. 32 The current maximum concentration of use (0.6%) in leave-on products, 33 according to the Council, is approximately the same as that reported in 2001 (0.7%). 2
The Expert Panel noted that Imidazolidinyl Urea is a formaldehyde-releasing preservative, and use of these types of ingredients as a whole has decreased. The Expert Panel determined that there were no new relevant data that necessitated a new re-review of this ingredient.
Footnotes
Author Contributions
The articles in this supplement were sponsored by the Cosmetic Ingredient Review.
Author’s Note
Unpublished sources cited in this report are available from the Director, Cosmetic Ingredient Review, 1620 L Street, NW, Suite 1200, Washington, DC 20036, USA.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The articles in this supplement were sponsored by the Cosmetic Ingredient Review. The Cosmetic Ingredient Review is financially supported by the Personal Care Products Council.
